$3.05 Earnings Per Share Expected for McKesson Co. (NYSE:MCK) This Quarter

Wall Street brokerages forecast that McKesson Co. (NYSE:MCK) will report earnings of $3.05 per share for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for McKesson’s earnings. The lowest EPS estimate is $2.90 and the highest is $3.17. McKesson posted earnings per share of $2.90 in the same quarter last year, which suggests a positive year-over-year growth rate of 5.2%. The company is expected to report its next quarterly earnings report on Thursday, July 25th.

On average, analysts expect that McKesson will report full-year earnings of $14.14 per share for the current year, with EPS estimates ranging from $14.07 to $14.20. For the next year, analysts anticipate that the business will post earnings of $15.25 per share, with EPS estimates ranging from $14.86 to $15.43. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of analysts that that provide coverage for McKesson.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, May 8th. The company reported $3.69 EPS for the quarter, topping analysts’ consensus estimates of $3.66 by $0.03. The company had revenue of $52.43 billion for the quarter, compared to the consensus estimate of $53.14 billion. McKesson had a return on equity of 29.02% and a net margin of 0.02%. The firm’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the previous year, the business earned $3.49 earnings per share.

Several equities research analysts have weighed in on the company. Zacks Investment Research cut McKesson from a “hold” rating to a “sell” rating in a research note on Thursday, May 2nd. ValuEngine raised McKesson from a “strong sell” rating to a “sell” rating in a research note on Wednesday, May 8th. Finally, Wolfe Research assumed coverage on McKesson in a research note on Tuesday, April 2nd. They set an “outperform” rating on the stock. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and five have issued a buy rating to the stock. McKesson has a consensus rating of “Hold” and an average target price of $132.39.

Shares of NYSE MCK opened at $131.80 on Wednesday. The stock’s 50 day moving average is $129.54. The company has a quick ratio of 0.58, a current ratio of 1.02 and a debt-to-equity ratio of 0.88. McKesson has a 1-year low of $106.11 and a 1-year high of $146.64. The company has a market capitalization of $24.44 billion, a PE ratio of 9.71, a P/E/G ratio of 1.32 and a beta of 1.08.

The firm also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Monday, June 3rd will be paid a dividend of $0.39 per share. The ex-dividend date is Friday, May 31st. This represents a $1.56 dividend on an annualized basis and a dividend yield of 1.18%. McKesson’s dividend payout ratio is 11.50%.

In other news, EVP Lori A. Schechter sold 2,766 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $133.59, for a total transaction of $369,509.94. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Brian Scott Tyler sold 1,488 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $125.49, for a total value of $186,729.12. Following the transaction, the chief executive officer now directly owns 12,192 shares in the company, valued at approximately $1,529,974.08. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,174 shares of company stock worth $804,583. Insiders own 0.87% of the company’s stock.

A number of large investors have recently made changes to their positions in the stock. Alpha Quant Advisors LLC lifted its holdings in McKesson by 0.7% during the first quarter. Alpha Quant Advisors LLC now owns 10,818 shares of the company’s stock worth $1,270,000 after buying an additional 78 shares during the period. Poehling Capital Management LLC lifted its holdings in McKesson by 1.3% during the first quarter. Poehling Capital Management LLC now owns 6,162 shares of the company’s stock worth $721,000 after buying an additional 80 shares during the period. Adirondack Trust Co. lifted its holdings in McKesson by 22.4% during the first quarter. Adirondack Trust Co. now owns 480 shares of the company’s stock worth $57,000 after buying an additional 88 shares during the period. YorkBridge Wealth Partners LLC lifted its holdings in McKesson by 8.1% during the first quarter. YorkBridge Wealth Partners LLC now owns 1,214 shares of the company’s stock worth $142,000 after buying an additional 91 shares during the period. Finally, Barrett Asset Management LLC lifted its holdings in McKesson by 11.4% during the first quarter. Barrett Asset Management LLC now owns 891 shares of the company’s stock worth $104,000 after buying an additional 91 shares during the period. 87.32% of the stock is currently owned by institutional investors.

McKesson Company Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Recommended Story: How to find the components of the quick ratio

Get a free copy of the Zacks research report on McKesson (MCK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.